Back
Genting Bhd Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
34
GEBHY
Genting Bhd
Last Price:
3.87
Seasonality Move:
9.52%
Sell
2
AGIO
Agios Pharmaceuticals
Last Price:
38.94
Seasonality Move:
20.75%
Sell
34
Genting Bhd (GEBHY)
is a Sell
Is Genting Bhd a Buy, Sell or Hold?
- The current Genting Bhd [GEBHY] share price is $3.87. The Score for GEBHY is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- GEBHY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
2
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $38.97. The Score for AGIO is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
GEBHY Stock Price Chart
What is Genting Bhd's stock price today?
-
The Genting Bhd share price today is $3.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GEBHY is experiencing selling pressure, which indicates risk of future bearish movement.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $38.97
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
GEBHY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 44.03 | Sell |
| Chaikin Money Flow: | -38018 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.82 - 4.22) | Sell |
| Bollinger Bands (100): | (4.28 - 5.26) | Sell |
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.2 | Sell |
| Relative Strength Index (14 RSI): | 28.25 | Sell |
| Chaikin Money Flow: | 740295 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.22 - 61.14) | Sell |
| Bollinger Bands (100): | (41.85 - 53.15) | Sell |
GEBHY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.91 | Sell |
| 20-day SMA: | 3.96 | Sell |
| 50-day SMA: | 4.46 | Sell |
| 200-day SMA: | 4.89 | Sell |
| 8-day EMA: | 3.89 | Sell |
| 20-day EMA: | 4.02 | Sell |
| 50-day EMA: | 4.33 | Sell |
| 200-day EMA: | 4.75 | Sell |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.4 | Sell |
| 20-day SMA: | 53.73 | Sell |
| 50-day SMA: | 49.6 | Sell |
| 200-day SMA: | 41.93 | Sell |
| 8-day EMA: | 46.69 | Sell |
| 20-day EMA: | 51.08 | Sell |
| 50-day EMA: | 50.45 | Sell |
| 200-day EMA: | 42.79 | Sell |
Genting Bhd Earnings Growth & GEBHY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
Genting Bhd Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agios Pharmaceuticals Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||